March 13, 2017 / 6:08 AM / 5 months ago

BRIEF-Tigenix NV announces top-line one-year results from Caremi clinical trial

March 13 (Reuters) - Tigenix Nv:

* Tigenix NV - announced top-line one-year results from Caremi clinical trial, an exploratory phase I/II study of Allocscs in acute myocardial infarction

* Tigenix NV - all safety objectives of study have been met

* Tigenix NV - larger reduction in infarct size was found in one pre-specified subgroup associated with poor long-term prognosis

* Tigenix NV - no immune-related adverse events have been recorded at one-year follow-up Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below